LASTACAFT is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Alcaftadine.
| Product ID | 42254-288_4b8c6afe-2d76-46c7-a23e-99db5e180ff6 |
| NDC | 42254-288 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LASTACAFT |
| Generic Name | Alcaftadine |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2010-11-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022134 |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | ALCAFTADINE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2010-11-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022134 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-11-01 |
| Inactivation Date | 2019-09-24 |
| Ingredient | Strength |
|---|---|
| ALCAFTADINE | 2.5 mg/mL |
| SPL SET ID: | 4b8c6afe-2d76-46c7-a23e-99db5e180ff6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-4290 | LASTACAFT | alcaftadine |
| 0023-4291 | LASTACAFT | alcaftadine |
| 42254-288 | LASTACAFT | alcaftadine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LASTACAFT 85168259 4071760 Live/Registered |
Allergan, Inc. 2010-11-03 |
![]() LASTACAFT 85088422 4003795 Live/Registered |
Allergan, Inc. 2010-07-20 |